IMMULOGIC Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMMULOGIC

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bosco who wrote (198)	9/24/1997 8:08:00 AM
From: Paul Getman	of 305

IMUL has a good IR department headed by Susan Primrose. I haven't talked to her in a while, but she's always been as helpful as she could be, considering all the bad news that's been coming down. I believe there's been no word on Cat because IMUL is still negotiating the trial design with the FDA--this has been going on for at least six months. Ragweed, of course, won't start again until next summer, assuming that IMUL gets an approvable trial design for it with the FDA by then. I don't see what would attract a corporate sponsor to IMUL at this point. With no ongoing trials and development on everything but Cat and Ragweed stopped, there will be no news flow (at least no positive news flow) until next year sometime, possibly late next year. Paul

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next